Report #2886990

Overview

Sex

Female

Age

Age unknown

State

WA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

conjunctival papillomatosis (CP) treated with 9-valent HPV vaccine/Although human papillomavirus (HPV) vaccine was originally developed for prevention,; Literature Report. This Literature (Spontaneous) report has been received from the authors of a published article, titled as stated above and referred to a 72-year-old Female patient. The patient's concurrent conditions included multiple papillomas and Conjunctival papillomatosis. The patient's past medications were not reported. The patient's concomitant medication included Interferon alfa-2b (Interferon alfa-2b) and Cimetidine (Cimetidine). On an unknown date, patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (dose, route of administration, lot# and expiration date were not reported) for the treatment of Conjunctival papillomatosis. It was reported that although human papillomavirus (HPV) vaccine was originally developed for prevention, it garnered interest for its potential therapeutic role in treating recurrent HPV-associated lesions (Off label use). A copy of the published article is attached as further documentation of the patient's experience. This is one of three cases derived from the same literature article (cross-referenced with case# 2386045 and 2386046).

Current illness

Papilloma; Papilloma conjunctival

Other medications

interferon alpha 2-b; interferon alpha 2-b; cimetidine